INmune Bio
INMB
11 hedge funds and large institutions have $1.64M invested in INmune Bio in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
1% more capital invested
Capital invested by funds: $1.62M → $1.64M (+$17K)
0.07% more ownership
Funds ownership: 2.54% → 2.62% (+0.07%)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$22.7K |
| 2 |
BlackRock
New York
|
+$12.5K |
| 3 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
+$4.82K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$2.41K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.07K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FAIM
1
Financial Advocates Investment Management
Olympia,
Washington
| $1.3M | – | – | – |
|
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $267K | +$22.7K | +4,715 | +11% |
|
|
3
BlackRock
New York
| $38K | +$12.5K | +2,597 | +66% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $10K | +$14 | +3 | +0.2% |
|
|
CCM
5
Covington Capital Management
Los Angeles,
California
| $6K | – | – | – |
|
|
TPWA
6
TRUE Private Wealth Advisors
Salem,
Oregon
| $5K | +$4.82K | +1,000 | New |
|
|
RG
7
Retirement Group
San Diego,
California
| $4K | +$3.38K | +700 | New |
|
|
ASN
8
Advisory Services Network
Atlanta,
Georgia
| $3K | +$2.41K | +500 | New |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
LTFS
10
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
11
Victory Capital Management
San Antonio,
Texas
| – | -$5K | -843 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$3.07K | -636 | -93% |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | -$1K | -204 | Closed |
|
INMB Hedge Fund Activity: Q4 2019 in Review
11 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q4 2019, worth a combined $1.64M — up 1% from $1.62M a quarter earlier.
Fund positioning in INMB was balanced in Q4 2019: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $22.7K. The largest seller was Victory Capital Management, exiting entirely with an estimated $5K sold.
- 11 institutional investors held INmune Bio (INMB) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $1.64M of INmune Bio stock for Q4 2019, up 1% quarter-over-quarter.
- 3 funds opened new INmune Bio positions in Q4 2019 and 3 closed out, a net change of 0 holders.
- The largest INmune Bio buyer in Q4 2019 was Deutsche Bank, an estimated $22.7K added.
- The largest INmune Bio seller in Q4 2019 was Victory Capital Management, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2019.